Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2013 01:16 ET | Source: Vifor Pharma Ltd.

New PDUFA action date announced by the US FDA for Injectafer® New Drug Application

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Vifor Pharma today announced that its US partner,...
March 12, 2013 02:15 ET | Source: Vifor Pharma Ltd.

Demande d'autorisation de PA21 déposée en Suisse

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Une demande d'autorisation de PA21 en Suisse a été...
March 12, 2013 02:15 ET | Source: Vifor Pharma Ltd.

Zulassungsantrag für PA21 in der Schweiz eingereicht

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Für PA21 wurde beim Schweizerischen Heilmittelinstitut...
March 12, 2013 02:15 ET | Source: Vifor Pharma Ltd.

PA21 authorisation application submitted in Switzerland

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} An application for the authorisation of PA21 in...
February 11, 2013 01:05 ET | Source: Vifor Pharma Ltd.

PA21 dossier submitted for approval to US FDA

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} The New Drug Application (NDA) for PA21 has been...
January 31, 2013 01:15 ET | Source: Vifor Pharma Ltd.

Observational study suggests a role for Ferinject® (ferric carboxymaltose) in optimizing the care of anaemic and iron deficient patients with cancer

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} On the eve of World Cancer Day, Vifor Pharma notes...
January 17, 2013 02:00 ET | Source: Vifor Pharma Ltd.

Vifor Pharma and China Medical System Holdings Limited sign distribution agreement for Maltofer® and Uro-Vaxom® in China

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Vifor Pharma, a company of the Galenica Group, today...
November 05, 2012 04:00 ET | Source: Vifor Pharma Ltd.

PA21 Pivotal phase III data presented at American Society of Nephrology (ASN) Kidney Week demonstrate successful control of hyperphosphatemia with lower pill burden for patients

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Data from a pivotal phase III clinical study of new...
September 26, 2012 07:00 ET | Source: Vifor Pharma Ltd.

Venofer® (Iron Sucrose Injection, USP) receives US FDA approval for Paediatric Indication

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Vifor Pharma, a company of the Galenica group, is...
September 17, 2012 04:00 ET | Source: Vifor Pharma Ltd.

New Guidelines Issued by a Number of Global Medical Committees Prioritise Management of Iron Deficiency to Improve Patient Outcomes

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} - The new Kidney Disease Guideline: Improving Global...